INFI +123% Up on being chosen to show its data at a Cancer society annual meeting. BofA analyst tripled its price target on the microcap. Not sure if any data was revealed, however.
ARDX +44% Lots of raised PTs after positive results on their second ph 3 trial with their irritable bowel syndrome drug. Good results were probably expected. Some PT raised to 19, some to 14. Stock closed at $7.80, well below its 52 week high of $16.30. Don't know this company's history.
ROKA +22% Not sure why this stock has rallied so much recently. No news. Nothing interesting on twitter.
SPAR +21% Up just because it presented a new strategy at an investor conference today. This is a $500M company, big enough that it will likely give half of those gains back tomorrow.
CDXS +17% Small cap biotech focusing on protein catalysts. Up on collaboration with Nestle Health Science, a subsidiary of the food company.
CCCR +16% One of many microcap Chinese finance companies. Up on no apparent news.
TRIL +14% A microcap oncology company. Up on slightly higher than average volume. No news.
POLA +13% Up on multi-unit purchase of DC systems for Puerto Rico. Is a microcap power systems company.
ZFGN +13% Received an inducement grant by the company for the CEO to buy shares.
RELL +13% Up on earnings, closed at the 52 week high.
CASI +11% A microcap biotech focused on cancer and unmet needs in China. But it's an American company. Up on the Chairman buying shares. Was already up 65% yesterday. Just on this news, I assume the stock will fade, it'snot up by company developments, and he had purchased stock at $1.83, much lower than the closing price of $3.64. Seems like stock could fade tomorrow.
ACRX -60% Got a CRL for its pain reliever drug. The FDA said ACRX didn't do enough studies with the trial. Stock closed at $2.15. Roth lowered PT to $7.50 from $12. Thinks the drug will just be delayed a year as another trial is done. Seems like the stock could rebound tomorrow.
JILL -51% Reported very bad earnings and sales trends. Lowered EPS and revenues dramatically.
HMNY -38% Crash after going parabolic. Moviepass received "doubt qualification" from auditor.
NSTG -28% Reported preliminary revenue miss. Cowen and Janney Capital dgs, says the company's business is downtrending.
WPCS -21% Gave back all of its gains and more from yesterday's rally. Is still up a little from a 3 day uptrend.
HAWK -20% Bad earnings. Its private gift card business isn't doing well.
TNDM -18% A small cap medical device company for people with insulin-dependent diabetes. Down on common stock/warrants offering.
ORPN -17% Retraced from a 50%+ rally yesterday. It had gone up only because of patent approval in teh EU. Patent approval rallies almost always fade, probably close to 100% of the time.
PTGX -15% Small cap bio. Down on secondary priced at $17. Fell below the offering price.
CBPO -15% Sells human plasma based products to hospitals. Down on news to acquire a company. Seems like a strange reason to fade, could rebound tomorrow.